1. Home
  2. ZIMV

ZIMV

ZimVie Inc.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-17-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.

Founded: 2021 Country:
United States
United States
Employees: 2600 City: WESTMINSTER
Market Cap: 417.3M IPO Year: N/A
Target Price: $16.00 AVG Volume (30 days): 376.6K
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -14.87 EPS Growth: N/A
52 Week Low/High: $6.52 - $20.91 Next Earning Date: 05-01-2024
Revenue: $457,433,000 Revenue Growth: -1.26%
Revenue Growth (this year): 1.25% Revenue Growth (next year): 1.09%

Share on Social Networks: